New Delhi: In a big victory for TB activism and children suffering from TB in India, the country’s patent office rejected Johnson & Johnson’s (J&J) patent application for the paediatric formulation of Bedaquiline on Friday, July 5.

New Delhi, 01/Oct/2023: In an unusual repetition of sorts, the Union health ministry issued a press release on Sunday, October 1, denying any shortages of essential medicines for drug-resistant TB patients. It was only on September 26 that the ministry issued an almost similar statement.

The number of HIV-infected people who go on to develop TB is increasing in India, according to the India TB Report 2019, which was released by the government on September 25, 2019.